Search Videos and More

Showing 61 - 72 of 154 results

Previous| 1... 5 | 6 | 7 ...13 |Next


New Directions in the Diagnosis and Treatment of Hematologic Cancers: Highlights from International Medical Meetings Course

New Directions in the Diagnosis and Treatment of Hematologic Cancers: Highlights from International Medical Meetings

This symposium will provide attendees with cutting-edge updates and perspectives on new diagnostic tools and management options of hematologic malignancies including genetic profiling, cytogenetics, molecular diagnostics, riskadaptive strategies, and novel therapies recently approved by the FDA.
Comprehensive Cancer Care Demands Exceptional Teamwork, Collaboration and Leaders to Bring It to Life. News

Comprehensive Cancer Care Demands Exceptional Teamwork, Collaboration and Leaders to Bring It to Life.

Centralizing scientific discovery, advanced research, and clinical care—all for a new therapeutic pathway.
New Fox Chase Clinical Trial Could Help Men With Intermediate-Risk Prostate Cancer Avoid Radical Treatment News

New Fox Chase Clinical Trial Could Help Men With Intermediate-Risk Prostate Cancer Avoid Radical Treatment

Could NanoKnife be the future of prostate cancer care?
A Salvage Treatment Jennifer Was Inspired to Salvage. News

A Salvage Treatment Jennifer Was Inspired to Salvage.

A Life-Saving Idea for Bladder Cancer Patients.
Fox Chase Cancer Center Researchers Present Further Data on Potential Bladder-Sparing Treatment News

Fox Chase Cancer Center Researchers Present Further Data on Potential Bladder-Sparing Treatment

Bladder removal is life-altering. This study examines when and why some patients may not need it.
Optimizing Treatment Strategies for Localized and Advanced Prostate Cancer Symposium

Optimizing Treatment Strategies for Localized and Advanced Prostate Cancer

View this symposium presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education. Learn the most current strategies for optimally managing localized and advanced prostate cancer from the Fox Chase Cancer Center genitourinary oncology team—nationally recognized physicians specializing in urology, radiation therapy, medical oncology, and radiology
Management of Early Stage Non-Small Cell Lung Cancer Symposium

Management of Early Stage Non-Small Cell Lung Cancer

This conference was presented by Fox Chase Cancer Center, the Temple Lung Center, and the Temple Health Office for Continuing Medical Education. It was designed as a forum for discussion of advances in technology and treatment of early stage non-small cell lung cancer. Multidisciplinary perspectives, including medical, surgical and radiation oncology, pulmonology, and radiology.
21st Annual Highlights of the 2022 San Antonio Breast Cancer Symposium Symposium

21st Annual Highlights of the 2022 San Antonio Breast Cancer Symposium

Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, these enduring materials help clinicians translate the data from key presentations from the 2022 San Antonio Breast Cancer Symposium into practice. View speakers from Fox Chase and Penn Medicine’s Abramson Cancer Center as they present information on the treatment of breast cancer, including screening, prevention, local control, chemotherapy, hormonal therapy, and advances in breast cancer biologics and their impact on breast cancer management.
A More Accurate, Less Invasive Analysis for Lung Cancers: RNA Next-Generation Sequencing News

A More Accurate, Less Invasive Analysis for Lung Cancers: RNA Next-Generation Sequencing

Genetically targeted therapy for lung cancer can make treatment much more effective, but identifying the specific gene fusions involved in the disease remains a challenge.
Bispecifics: A Molecular Missile That Labels Cancer Cells and Kills Them News

Bispecifics: A Molecular Missile That Labels Cancer Cells and Kills Them

A relatively new classification of immunotherapeutic drugs is pushing the outer limits of late-line treatment, bringing new hope to patients and the cancer community. They’re bispecific antibodies.
Cancer Is a Moving Target.<br>CBCT-Based Adaptive Radiation Therapy Tracks It Every Day of Treatment. News

Cancer Is a Moving Target.
CBCT-Based Adaptive Radiation Therapy Tracks It Every Day of Treatment.

Adaptive radiation therapy allows clinicians to make daily adjustments in a patient’s treatment in real time while the patient is on the treatment table based on the cancer’s response to the radiation, position of the tumor, and the location of the adjacent normal organs.
The New Department of Urology at Fox Chase Cancer Center News

The New Department of Urology at Fox Chase Cancer Center

Built on strength: world-class specialists, innovative researchers, and clinical leaders.

Showing 61 - 72 of 154 results

Previous| 1... 5 | 6 | 7 ...13 |Next